The advent of the molecular world opening up for familial adenomatous polyposis and other genetically predisposed cancers has now provided us with wonderful tools to study these diseases. The challenges, however, clearly remain to transfer discoveries in the laboratory to improvements in the care of these patients.
BapatB.V., OdzeR., MitriA.Identification of somatic APC gene mutations in periampullary carcinomas in a patient with FAP.Human Molec Genet1993; 2: 1957–9
2.
BapatB.V., ParkerJ.A., BerkT.Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines.Dis Colon Rectum1994; 37: 165–71
3.
BapatB.V., BerkT., MitriA.Characterization of two novel APC gene mutations in patients with FAP.Human Mut1994; 4: 253–6
4.
BerkT., CohenZ., CullenJ.B.. Familial Polyposis and the role of the preventive registry.Can Med Assoc J1981; 124: 1427–8
5.
BerkT., CohenZ., McLeodR.. Four years experience of the Canadian Familial Polyposis Registry.Br J Surg1985; 72(Suppl): S137
6.
ParkerJ.A., KalninsV., DeckJ.H.N.Histopathological features of congenital fundus lesions in familial adenomatous polyposis.Can J Ophthal1990; 3: 159–63
7.
SternH.S., GregoireR.C., KashtanH.Long term effects of calcium on risk markers for colon cancer in familial adenomatous polyposis patients. In: UtsunomiyaJ., LynchH.T., eds. Hereditary Colorectal Cancer.Tokyo: Springer-Verlag, 1990: 283–9
8.
LevittA.J., RodinG., CohenZ., BerkT.. Coping styles, psychopathology and intellectual performance in patients with familial adenomatous polyposis.Gen Hosp Psychiatry1992; 14: 61–8
9.
BerkT., CohenZ., McLeodR.S., SternH.S.. Management of mesenteric desmoid tumours in familial polyposis.Can J Surg1992; 4: 393–5
10.
FishelR., LascoeK., RaoM.R.S.The human mutator gene homolog MSH 2 and its association with hereditary non-polyposis colon cancer.Cell1993; 75: 1027–38
